Corvus Pharmaceuticals, Inc. (CRVS) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -10.37M | -9.19M | -9.57M | -5.78M | -8.26M | -8.46M | -6.32M | -5.48M | -5.16M | -5.17M | -5.43M | -5.22M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -25.55% | -8.58% | -51.34% | -5.4% | -60.23% | -63.83% | -16.32% | -4.94% | 36.42% | 31.54% | 21.58% | 14.7% |
| Net Income | -13.69M | -12.32M | -10.16M | -8M | 15.19M | -12.11M | -40.22M | -4.26M | -5.7M | -6.65M | -6M | -6.5M |
| Depreciation & Amortization | 29K | 26K | 28K | 29K | 22K | 20K | 21K | 21K | 23K | 28K | 30K | 36K |
| Stock-Based Compensation | 2.65M | 1.57M | 1.25M | 1.26M | 1.25M | 845K | 701K | 768K | 689K | 572K | 546K | 537K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 582K | 446K | -136K | -1.96M | -24.88M | 4.24M | 32.85M | -1.46M | -387K | 1.28M | 620K | 1.03M |
| Working Capital Changes | 57K | 1.08M | -550K | 2.89M | 152K | -1.46M | 326K | -545K | 219K | -391K | -630K | -319K |
| Change in Receivables | -6K | -5K | 54K | -7K | -4K | -5K | -35K | -9K | 0 | -15K | -11K | 429K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 2.21M | 517K | -1.16M | 1.83M | -1.27M | 709K | 660K | -396K | 84K | 121K | -694K | 691K |
| Cash from Investing | -144.85M | 10.88M | -2.62M | -20.3M | 4.24M | -6.08M | -3.89M | -17.5M | -7K | -2.32M | 17.55M | -4.29M |
| Capital Expenditures | -91K | -25K | 0 | -113K | -36K | 5K | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 190.75M | 20K | 360K | 35.77M | 279K | 18.61M | 50K | 30.37M | 0 | 0 | 335K | 7.52M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 190.75M | 20K | 360K | 35.77M | 279K | 18.61M | 50K | 30.37M | 0 | 0 | 327K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8K | 7.52M |
| Net Change in Cash | 35.53M | 1.71M | -11.82M | 9.69M | -3.74M | 4.06M | -10.16M | 7.38M | -5.16M | -7.49M | 12.45M | -2M |
| Free Cash Flow | -10.46M | -9.22M | -9.57M | -5.89M | -8.3M | -8.46M | -6.32M | -5.48M | -5.16M | -5.17M | -5.43M | -5.22M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -26.1% | -8.87% | -51.34% | -7.46% | -60.93% | -63.83% | -16.32% | -4.94% | 36.69% | 31.57% | 24.46% | 14.75% |
| FCF per Share | -0.12 | -0.12 | -0.12 | -0.08 | -0.11 | -0.12 | -0.09 | -0.09 | -0.11 | -0.11 | -0.11 | -0.11 |
| FCF Conversion (FCF/Net Income) | 0.76x | 0.75x | 0.94x | 0.72x | -0.54x | 0.70x | 0.16x | 1.29x | 0.90x | 0.78x | 0.91x | 0.80x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |